NVGS Intrinsic Value

Intrinsic Value of NVGS Overview

Key Highlights:
As of Mar 11, 2025 NVGS Relative Value is $32.7, which is undervalued by 137.3%, compared to current share price of $13.8.
As of Mar 11, 2025 NVGS DCF Value is N/A, which is undervalued by N/A, compared to current share price of $13.8.
Methodology
Price per share, $
Current share price
13.8
DCF value
not available

NVGS Historical Intrinsic Value

Crunching data... Almost there!
Crunching data... Almost there!

NVGS Valuation Metrics

LTM
NTM
1Y Forward
2Y Forward
EV/Revenue
2.5x (as of Mar 11, 2025)
EV/Gross Profit
7.8x (as of Mar 11, 2025)
EV/EBIT
9.8x (as of Mar 11, 2025)
EV/EBITDA
5.4x (as of Mar 11, 2025)
EV/FCF
6.4x (as of Mar 11, 2025)
EV/OCF
5.8x (as of Mar 11, 2025)
P/Revenue
1.7x (as of Mar 11, 2025)
P/Gross Profit
5.3x (as of Mar 11, 2025)
P/EBIT
6.7x (as of Mar 11, 2025)
P/EBITDA
3.7x (as of Mar 11, 2025)
P/FCF
4.4x (as of Mar 11, 2025)
P/OCF
3.9x (as of Mar 11, 2025)
P/E
11.6x (as of Mar 11, 2025)
P/BV
0.8x (as of Mar 11, 2025)
PEG 1Y
0.8x (as of Mar 11, 2025)

NVGS DCF Model

Free Cash Flow to Firm Model
NOPAT Model
Free Cash Flow to Equity Model
Net Income Model
Millions
Billions
Dec'19 ActualDec'20 ActualDec'21 ActualDec'22 ActualDec'23 ActualDec'24 EstimateDec'25 EstimateDec'26 EstimateDec'27 EstimateDec'28 EstimateDec'29 EstimateDec'30 EstimateDec'31 EstimateDec'32 EstimateDec'33 EstimateDec'34 Terminal
% growth
301.4
(2.8%)
332.5
10.3%
403.6
21.4%
473.8
17.4%
550.7
16.2%
517.4
(6.1%)
548.6
6.0%
566.3
3.2%
1,008.7
78.1%
1,686.4
67.2%
2,634.8
56.2%
3,827.9
45.3%
5,142.5
34.3%
6,345.5
23.4%
7,135.3
12.4%
7,242.3
1.5%
32.6
10.8%
41.8
12.6%
56.4
14.0%
(70.5)
(14.9%)
137.2
24.9%
84.2
16.3%
89.3
16.3%
92.2
16.3%
164.3
16.3%
274.6
16.3%
429.0
16.3%
623.3
16.3%
837.4
16.3%
1,033.2
16.3%
1,161.8
16.3%
1,179.3
16.3%
NOPAT
% effective tax rate
33.4
11.1%
21.6
6.5%
58.5
14.5%
(58.5)
(12.4%)
128.8
23.4%
79.1
15.3%
83.9
15.3%
86.6
15.3%
154.2
15.3%
257.8
15.3%
402.7
15.3%
585.1
15.3%
786.1
15.3%
969.9
15.3%
1,090.7
15.3%
1,107.0
15.3%
% of revenue
76.2
25.3%
76.7
23.1%
88.5
21.9%
126.2
26.6%
129.2
23.5%
124.2
24.0%
131.7
24.0%
136.0
24.0%
242.2
24.0%
404.9
24.0%
632.6
24.0%
919.0
24.0%
1,234.6
24.0%
1,523.4
24.0%
1,713.1
24.0%
1,738.8
24.0%
% of revenue
(3.3)
(1.1%)
(2.3)
(0.7%)
(3.5)
(0.9%)
(45.8)
(9.7%)
(192.0)
(34.9%)
(78.3)
(15.1%)
(83.0)
(15.1%)
(85.7)
(15.1%)
(152.6)
(15.1%)
(255.2)
(15.1%)
(398.7)
(15.1%)
(579.2)
(15.1%)
(778.1)
(15.1%)
(960.1)
(15.1%)
(1,079.6)
(15.1%)
(1,095.8)
(15.1%)
(0.4)
(0.1%)
(26.9)
(8.1%)
17.2
4.3%
15.9
3.4%
(18.0)
(3.3%)
7.5
1.4%
7.9
1.4%
8.2
1.4%
14.6
1.4%
24.4
1.4%
38.1
1.4%
55.4
1.4%
74.4
1.4%
91.9
1.4%
103.3
1.4%
104.8
1.4%
Free Cash Flow to Firm (FCFF)
% of revenue
105.9
35.1%
69.1
20.8%
160.7
39.8%
37.8
8.0%
48.0
8.7%
132.5
25.6%
140.5
25.6%
145.0
25.6%
258.3
25.6%
431.9
25.6%
674.8
25.6%
980.4
25.6%
1,317.0
25.6%
1,625.1
25.6%
1,827.4
25.6%
1,854.8
25.6%
% of FCFF used in calculation
Discount period
Discount factor
Discounted FCFF (DFCFF)

NVGS DCF Value

Crunching data... Almost there!

NVGS Earnings Power Value and Enterprise Value

Annual
LTM
Enterprise Value Breakdown
EPV and MIVoG as % of EV

NVGS Reverse DCF

Implied FCF growth
Implied Revenue growth

Reverse DCF Assumptions and Outputs

as of Sep 30, 2024
Long-Term growth rate
1.5%
FX rate
1.0
Last share price
16.0
Implied FCF growth 1-10Y
0.0%

Implied Free Cash Flow growth vs Historical average vs Industry growth

Competing with NVGS Intrinsic Value

Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Company name
Market Cap
Enterprise Value
Intrinsic Value
DCF Value
Relative value
Ben Graham Revised fair value
Peter Lynch fair value
Earnings Power Value (EPV), % of EV
Market-Implied Value of Growth (MIVoG), % of EV
Reverse DCF (implied FCF growth)
Reverse DCF (implied Revenue growth)
$952.0M
$1,390.2M
$32.9
138.6% undervalued
N/A
$32.9
138.6% undervalued
$21.6
56.5% undervalued
$30.6
121.6% undervalued
N/A
N/A
0.0%
0.0%
$92.7B
$99.2B
$71.2
68.4% undervalued
$78.0
84.0% undervalued
$64.5
52.4% undervalued
$0.6
98.7% overvalued
$79.0
86.7% undervalued
60.1%
39.9%
(5.2%)
(9.2%)
$73.6B
$105.3B
$105.8
218.9% undervalued
$163.5
393.0% undervalued
$48.1
44.9% undervalued
$33.4
0.6% undervalued
$34.7
4.5% undervalued
104.9%
(4.9%)
0.6%
0.4%
$66.7B
$93.6B
$43.2
21.4% overvalued
$48.5
12.0% overvalued
$37.9
31.1% overvalued
$35.6
35.1% overvalued
$31.4
42.9% overvalued
41.7%
58.3%
6.2%
3.8%
$61.1B
$121.3B
$48.2
170.1% undervalued
$57.2
221.0% undervalued
$39.1
119.4% undervalued
$27.4
53.8% undervalued
$30.5
71.2% undervalued
101.0%
(1.0%)
(18.5%)
(15.3%)
$58.5B
$90.1B
$31.5
19.2% undervalued
$42.1
59.0% undervalued
$20.9
21.0% overvalued
$0.0
100.0% overvalued
$14.7
44.2% overvalued
64.6%
35.4%
(1.0%)
(3.5%)
$54.0B
$85.3B
$260.5
181.2% undervalued
$435.0
370.0% undervalued
$86.0
7.2% overvalued
$67.5
27.1% overvalued
$77.5
16.4% overvalued
53.4%
46.6%
4.2%
4.0%
$53.4B
$73.4B
$101.2
92.7% undervalued
$128.0
144.0% undervalued
$74.4
41.7% undervalued
$37.8
28.0% overvalued
$41.1
21.7% overvalued
93.4%
6.6%
(7.7%)
(6.7%)
$48.2B
$89.2B
$43.1
6.9% overvalued
Negative
123.0% overvalued
$43.1
6.9% overvalued
Negative
134.7% overvalued
$6.0
86.9% overvalued
88.0%
12.0%
6.0%
13.2%
$39.9B
$54.0B
$91.9
49.3% overvalued
N/A
$91.9
49.3% overvalued
$227.0
25.3% undervalued
$178.5
1.5% overvalued
48.5%
51.5%
20.0%
25.0%
$22.3B
$31.4B
$22.5
41.2% overvalued
$15.0
61.0% overvalued
$30.1
21.4% overvalued
$20.6
46.2% overvalued
$23.2
39.5% overvalued
82.4%
17.6%
(0.9%)
(0.1%)

Intrinsic Valuation Tools

Wondering how to calculate intrinsic value of a stock? Use our intrinsic value tools to simplify complex valuation concepts and save time.